RE:RE:Bring back Beaudet It's a small world out there and people always go to those they confide in and trust. Perhaps Goodman did have discussions with his trusted network on things.
I think it's early yet to judge the impact Samira has and will have on Knight. Covid no doubt delayed the integration of Biotiscana which pushed back or delayed the return trajectory of that acquisition.
Knight is due for a market update and it will be very interesting to see what the capital framework looks like going forward and what the deal landscape will deliver.
I have no doubt they are very busy behind the scenes in developing on investment options and scenarios.
LR